MannkindLogoStackedPreferd.jpg
MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO
January 12, 2015 07:00 ET | MannKind
VALENCIA, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a biopharmaceutical-based technology company, today announced that Alfred Mann, the company's founder, retired...
MannkindLogoStackedPreferd.jpg
MannKind Earns $50 Million in Milestone Payments From Sanofi
January 08, 2015 07:00 ET | MannKind
VALENCIA, Calif., Jan. 8, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it has earned a total of $50 million in milestone payments in connection with the...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Present at the J.P. Morgan 2015 Healthcare Conference
January 07, 2015 17:00 ET | MannKind
VALENCIA, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference
November 25, 2014 17:00 ET | MannKind
VALENCIA, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that...
MannkindLogoStackedPreferd.jpg
MannKind Corporation Reports 2014 Third Quarter Financial Results
November 03, 2014 09:00 ET | MannKind
VALENCIA, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the third quarter ended September 30, 2014. For the third quarter of 2014,...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3, 2014
October 27, 2014 17:00 ET | MannKind
VALENCIA, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2014 third quarter financial results on Monday, November 3, 2014 and its management will host a...
MannkindLogoStackedPreferd.jpg
MannKind Announces Receipt of $150 Million Licensing Upfront Payment
September 29, 2014 19:29 ET | MannKind
VALENCIA, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it had received a $150 million upfront payment in connection with an exclusive worldwide...
MannkindLogoStackedPreferd.jpg
MannKind Announces Closing of Global Licensing Agreement With Sanofi
September 24, 2014 17:00 ET | MannKind
VALENCIA, Calif., Sept. 24, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced the closing of a worldwide exclusive collaboration and licensing agreement with Sanofi for...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference
September 02, 2014 17:00 ET | MannKind
VALENCIA, Calif., Sept. 2, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that...
MannkindLogoStackedPreferd.jpg
MannKind Corporation Reports 2014 Second Quarter Financial Results
August 11, 2014 09:00 ET | MannKind
VALENCIA, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the second quarter ended June 30, 2014. For the second quarter of 2014,...